Publications - BioPharm Laboratories

PUBLICATIONS

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy. Katharine A Parker; Sharon Glaysher; Marta Ewa Polak; Francis G Gabriel; Penny Johnson; Louise A Knight; Matthew Poole; Ajit Narayanan; Jeremy Hurren; Ian Cree. British Journal of Cancer 2010;103(5):656-62.
The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapy. Sharon Glaysher; Dennis Yiannakis; Francis G Gabriel; Penny Johnson; Marta Ewa Polak; Louise A Knight; Zoe Goldthorpe; Katharine Peregrin; Mya Gyi; Paul Modi; Joe Rahamim; Mark E Smith; Khalid Amer; Bruce Addis; Matthew Poole; Ajit Narayanan; Tim J Gulliford; Peter E Andreotti; Ian Cree. Journal of clinical pathology 2010;63(11):1012-20.
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). Glaysher S1, Yiannakis D, Gabriel FG; Johnson P, Polak ME, Knight LA, Goldthorpe Z, Peregrin K, Gyi M, Modi P, Rahamim J, Smith ME, Amer K, Addis B, Poole M, Narayanan A, Gulliford TJ, Andreotti PE, Cree IA. BMC Cancer. 2009 Aug 27;9:300. doi: 10.1186/1471-2407-9-300.
Cell sensitivity assays: the ATP-based tumor chemosensitivity assay. Sharon Glaysher; Ian Cree, Methods in molecular biology (Clifton, N.J.) 2011;731():247-57.
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma; Sanjay Sharma, Michael H Neale, Federica Di Nicolantonio, Louise A Knight, Pauline A Whitehouse, Stuart J Mercer, Bernard R Higgins, Alan Lamont, Richard Osborne, Andrew C Hindley, Christian M Kurbacher and Ian A Cree. BMC Cancer 2003, 3:19;
Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements. Federica Di Nicolantonio; Louise A Knight; Pauline A Whitehouse; Stuart J Mercer; Sanjay Sharma; Peter A Charlton; David Norris; Ian Cree. Methods in molecular medicine 2005;110():101-20.
The GAB2 signalling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. Mira A, Isella C, Renzulli T, Cantarella D, Martelli ML, Medico E. Oncogene. 2009 Dec 17;28(50):4444-55.
Resistance/response molecular signature for oral tongue squamous cell carcinoma. Amritha Suresh, Muhil Vannan, Dhanya Kumaran, Zeynep H. Gumus, Priya Sivadasa, Elango Erode Murugaian, Vikram Kekatpure, Subramanian Iyer, Kumarasamy Thangaraj and Moni Abraham Kuriakose, Disease Markers 32 (2012) 51–64.